Beta-blockade--rational or irrational therapy for congestive heart failure?
- 1 November 1987
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 76 (5) , 971-973
- https://doi.org/10.1161/01.cir.76.5.971
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Neurohumoral mechanisms involved in congestive heart failureThe American Journal of Cardiology, 1985
- Inotropic drugs and their mechanisms of actionJournal of the American College of Cardiology, 1984
- Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1983
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failureThe American Journal of Cardiology, 1982
- Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist PirbuterolNew England Journal of Medicine, 1981
- Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.Heart, 1980
- Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.Heart, 1980
- Plasma norepinephrine in congestive heart failurePublished by Elsevier ,1978